AMSA Pharm-free Scorecard 2010
B Georgia Health Sciences University
City: Augusta State: GA
Commentary:

Summary: Georgia Health Sciences University (formerly Medical College of Georgia) provides a policy which makes good strides in the area of speaking and consulting relationships. However it does not go far enough to ban gifts, limit drug samples as a marketing tool, or establish sufficient firewalls in procurement. The policy has an improved disclosure policy requiring now internal disclosure and giving guidelines for public disclosure but not mandating this.

Demographics: On average, students spend 70% of their time at Georgia Health Sciences University Health System, 10% at Augusta Veterans Administration Medical Center, and 8% at Phoebe Putney Memorial Hospital. Submitted policies apply to Georgia Health Sciences University Health System.

Updates: This institution did not submit any new or additional policies for the 2012-3 AMSA PharmFree Scorecard. 

 

This institution's evaluation was last updated: 4/9/2013.



Gifts & Meals 2 School of Medicine employees may accept gifts that total below a $25 threshold per year; university recipients are limited to $100 threshold.
Consulting relationships 2 There is a requirement for institutional review, but no specifics on formal contracts or ensuring that payment is appropriate.
Industry-funded speaking relationships 3 This policy explicitly stipulates that faculty may only present for an event sponsored or partially-sponsored by industry if "the activity "is not an Industry-sponsored “speaker’s bureau” (i.e., a contractual relationship to give talks in which the topic(s) and/or content are provided by the company). and if the "participant is not required by an Industry sponsor to accept advice or services concerning speakers, content, etc., as a condition of the sponsor's contribution of funds or services."
Disclosure 2 The policy does not explicitly require public disclosure or disclosure to patients (though includes them as suggestions for individualized disclosure plans), but does require annual review.
Pharmaceutical samples 2 Samples must be controlled by the pharmacy.
Purchasing & Formularies 2 Individuals having a direct role making institutional decisions on equipment or drug procurement must disclose to the purchasing unit or selection committee any financial interest they or their immediate family have in companies that might benefit from the decision. The purchasing unit, following the applicable guidelines, will decide whether the individual must recuse him/herself from the purchasing decision.
Industry Sales Representatives 2 Industry representatives are allowed on-site only by appointment in non-patient care areas.
On-campus Education 2 All CME-accredited activity must adhere to ACCME guidelines, and "Industry support may not influence curriculum in any way" of non-CME accredited activity.                                 

Additionally, "Support must be designated for a broadly defined topic (e.g., cardiology, psychiatry, neurosurgery) or recurring educational activity (e.g., grand rounds). Support may not be designated for a specific topic, speaker or activity. "In kind" Industry support such as equipment and supplies may be designated to an activity.
Attendance at Industry-Sponsored Lectures & Meetings Off-Campus 3 Students and staff may not accept payment for attendance at industry-sponsored events.
Industry Support for Scholarships & Funds for Trainees 3 This policy requires that the institution have sole responsibility for selecting the recipient of scholarship funds, and that the recipient of any industry-funded scholarship not be subject to any quid pro quo.
Medical school curriculum 3 Curricular materials provided cover industry marketing's influence on medical decision-making as well as conflicts of interest in research.
Do the policies specify an oversight mechanism? Yes This policy establishes oversight.
Are there explicit sanctions for noncompliance? Yes This policy establishes sanctions for non-compliance.
What the results mean...
3Model policy
2Good progress toward model policy
1No policy, or policy unlikely to have a substantial effect on behavior
0Did not report
N/APolicy not relevant to this institution (e.g., does not make purchasing decisions)